Immunotherapeutic tumor treatment method
US12054553B2 · kind B2 · utility
0Cited by
8References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 2, 2018 |
| Grant date | Aug 6, 2024 |
| Priority date | — |
| Expiry date | Mar 30, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/75
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided is a method of administering to a patient having cancer: (a) a 4-1BB agonist; (b) an IL-2Rβ-activating amount of a long-acting, IL-2Rβ-selective agonist; and/or (c) a toll-like receptor agonist, as well as related compositions, kits and compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.